Atlas of Human Milk Nutrients

NCT01894893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2016-01-05

No results posted yet for this study

Summary

The main objective of this clinical trial is to collect human milk samples from 0 to 4 months after delivery in order to characterize human milk components. The secondary objectives of this study are:

1. To assess whether there is a correlation between human milk composition and mothers' diet
2. To assess whether there is a correlation between human milk composition and maternal clinical parameters
3. To assess whether there is a correlation between human milk composition and mother and infant clinical parameters

Conditions

  • Breastfeeding Mothers

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Claude Billeaud, Prof · University Hospital, Bordeaux

  • Jean-Charles Picaud, Prof · Hôpital de la Croix-Rousse

  • Thameur Rakza, Dr · CHRU de Lille

  • Massimo Agosti, Dr · Ospedale del Ponte Varese

  • Tom Stiris, Dr · Oslo University Hospital

  • Silva Gorett, Dr · Hospital de S. João Porto

  • Almerinda Barroso Pereira, Dr · Hospital de São Marcos - Braga

  • Maria Jose Costeira, Dr · Guimarães Hospital Braga

  • Isam Al-Jashi, Dr · Al Jashi Isam Private Med. Practice Bucharest

  • Sylvia Stoicescu, Dr · Polizu Hospital Bucharest

  • Cecilia Martinez-Costa, Dr · Hospital Clínico Universitario de Valencia

  • Magnus Domellöf,, Dr · Umeå University

  • Mireille Vanpeé, Dr · Karolinska University hospital in Solna

  • Giovanna Marchini, Dr · Karolinska University hospital in Solna

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • France
  • Italy
  • Norway
  • Portugal
  • Romania
  • Spain
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01894893 on ClinicalTrials.gov